Table 3.
Parameter | Youden index | Sensitivity (%) | 95% CI (sensitivity) | Specificity (%) | 95% CI (specificity) | PPV (%) | 95% CI (PPV) | NPV (%) | 95% CI (NPV) | Sum |
---|---|---|---|---|---|---|---|---|---|---|
Margins | 0.51 | 66.33 | 56.51–74.91 | 84.54 | 78.99–88,83 | 67.01 | 57.16–75.56 | 84.13 | 78.56–88.47 | 302.01 |
Markedly hypoechoic | 0.21 | 28.57 | 20.57–38.19 | 92.75 | 88.39–95.56 | 65.12 | 50.17–77.58 | 73.28 | 67.62–78.28 | 259.72 |
Microcalcifications | 0.37 | 64.29 | 54.43–73.07 | 72.95 | 66.52–78.54 | 52.94 | 44.02–61.68 | 81.18 | 74.96–86.15 | 271.36 |
Thyroid capsule infiltration | 0.22 | 37.76 | 28.79–47.64 | 84.06 | 78.46–88.42 | 52.86 | 41.32–64.10 | 74.04 | 68.08–79.23 | 248.71 |
Macrocalcifications | 0.21 | 38.78 | 29.73–48.67 | 82.61 | 76.86–87.17 | 51.35 | 40.18–62.39 | 74.03 | 68.01–79.25 | 246.76 |
Asteria scale | 0.34 | 44.90 | 35.43–54.75 | 89.37 | 84.43–92.88 | 66.67 | 54.66–76.84 | 77.41 | 71.69–82.25 | 278.34 |
“Halo” pattern | 0.17 | 94.90 | 88.61–97.80 | 21.74 | 16.66–27.85 | 36.47 | 30.80–42.54 | 90.00 | 78.64–95.65 | 243.11 |
Composition (solid) | 0.16 | 69.39 | 59.68–77.64 | 46.86 | 40.18–53.65 | 38.20 | 31.38–45.52 | 76.38 | 68.28–82.92 | 230.83 |
Tall/wide | 0.17 | 68.37 | 58.62–76.73 | 48.31 | 41.59–55.09 | 38.51 | 31.60–45.91 | 76.34 | 68.37–82.80 | 231.52 |